Improving Human Papillomavirus (HPV) Vaccine Uptake in Canada: A Call for Equity and Inclusivity.

IF 1.8
Noah Doucette, Audrey Steenbeek
{"title":"Improving Human Papillomavirus (HPV) Vaccine Uptake in Canada: A Call for Equity and Inclusivity.","authors":"Noah Doucette, Audrey Steenbeek","doi":"10.1177/2752535X251368427","DOIUrl":null,"url":null,"abstract":"<p><p>Human Papillomavirus (HPV) is the most common sexually transmitted infection worldwide. Specifically, HPV is responsible for a large proportion of anal, cervical, vaginal, vulvar, penile and oropharyngeal cancers, highlighting the importance of optimizing the prevention of this public health issue. To date, vaccination is the most effective method for preventing HPV-related infections and associated diseases; however, vaccine uptake remains well below national targets. In Canada, gender-neutral HPV vaccination is recommended for all individuals between nine and 26 years, but can also be administered to adults until the age of 45. Despite widespread adoption of publicly-funded school-based vaccination programs, some populations report disproportionately lower rates of HPV vaccine uptake, including young adults, transgender peoples and men who have sex with men (MSM), rendering them vulnerable to morbidity and mortality. Addressing HPV-related disparities requires a coordinated, multi-level call to action involving collaboration between academic and community partners to normalize inclusive, gender-neutral vaccination. This paper explores opportunities for optimizing HPV vaccine uptake in Canada by emphasizing the importance of healthcare provider recommendation, improved access to community-based vaccination services, and representation of diverse populations (e.g., young adults, transgender peoples, MSM) in the development and delivery of vaccine communication/messaging. The time is now to normalize inclusive HPV vaccination in order to mitigate the persistence of vaccine-related disparities and strive toward global initiatives of health equity.</p>","PeriodicalId":72648,"journal":{"name":"Community health equity research & policy","volume":" ","pages":"2752535X251368427"},"PeriodicalIF":1.8000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Community health equity research & policy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/2752535X251368427","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Human Papillomavirus (HPV) is the most common sexually transmitted infection worldwide. Specifically, HPV is responsible for a large proportion of anal, cervical, vaginal, vulvar, penile and oropharyngeal cancers, highlighting the importance of optimizing the prevention of this public health issue. To date, vaccination is the most effective method for preventing HPV-related infections and associated diseases; however, vaccine uptake remains well below national targets. In Canada, gender-neutral HPV vaccination is recommended for all individuals between nine and 26 years, but can also be administered to adults until the age of 45. Despite widespread adoption of publicly-funded school-based vaccination programs, some populations report disproportionately lower rates of HPV vaccine uptake, including young adults, transgender peoples and men who have sex with men (MSM), rendering them vulnerable to morbidity and mortality. Addressing HPV-related disparities requires a coordinated, multi-level call to action involving collaboration between academic and community partners to normalize inclusive, gender-neutral vaccination. This paper explores opportunities for optimizing HPV vaccine uptake in Canada by emphasizing the importance of healthcare provider recommendation, improved access to community-based vaccination services, and representation of diverse populations (e.g., young adults, transgender peoples, MSM) in the development and delivery of vaccine communication/messaging. The time is now to normalize inclusive HPV vaccination in order to mitigate the persistence of vaccine-related disparities and strive toward global initiatives of health equity.

改善加拿大人乳头瘤病毒(HPV)疫苗的摄取:呼吁公平和包容。
人乳头瘤病毒(HPV)是世界上最常见的性传播感染。具体而言,HPV是肛门癌、宫颈癌、阴道癌、外阴癌、阴茎癌和口咽癌的主要原因,突出了优化预防这一公共卫生问题的重要性。迄今为止,疫苗接种是预防hpv相关感染和相关疾病的最有效方法;然而,疫苗摄取仍然远低于国家目标。在加拿大,建议所有9至26岁的人接种不分性别的HPV疫苗,但也可以给45岁以下的成年人接种。尽管广泛采用了公共资助的学校疫苗接种计划,但一些人群报告的HPV疫苗接种率低得不成比例,包括年轻人、跨性别者和男男性行为者(MSM),使他们容易发病和死亡。要解决与人乳头瘤病毒有关的差异,需要协调、多层次的行动呼吁,涉及学术界和社区伙伴之间的合作,使包容性、中性的疫苗接种正常化。本文探讨了优化加拿大HPV疫苗接种的机会,强调了卫生保健提供者推荐的重要性,改善了社区疫苗接种服务的可及性,以及不同人群(如年轻人、变性人、男男性行为者)在疫苗传播/信息的开发和提供中的代表性。现在是使包容性人乳头瘤病毒疫苗接种正常化的时候了,以便减轻持续存在的疫苗相关差异,并努力实现卫生公平的全球倡议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.70
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信